Jump to content

Johanna Olson-Kennedy

Add links
From Wikipedia, the free encyclopedia
Johanna Olson-Kennedy
Alma materChicago Medical School, Children's Hospital Los Angeles
OccupationPhysician

Johanna Olson-Kennedy is an American physician who specializes in the care of children and teenagers with gender dysphoria and youth with HIV and chronic pain. She is board-certified in pediatrics and adolescent medicine and is the medical director of the Center for Transyouth Health and Development at Children's Hospital Los Angeles.[1][2]

Olson-Kennedy has co-authored multiple studies on transgender youth.[3][4][5] She also has been interviewed for multiple news pieces,[6][7][8][9] has served as a frequent expert witness in court cases, and as of 2024 is the president-elect of the United States Professional Association for Transgender Health (USPATH).[10]

Biography

[edit]

Olson-Kennedy is the co-author of multiple of studies on transgender youth. These include studies on chest reconstruction,[3] gender identity development,[4] physiological responses to gender-affirming hormones,[5] and the use of puberty blockers.[11] She has been described as "one of the country’s most vocal advocates of adolescent gender treatments",[10][by whom?] one of the "most celebrated youth gender medicine clinicians in the world",[12][by whom?] and is known as a critic of youth gender medicine protocols that require in-depth assessments before prescribing such hormones or puberty blockers, viewing them as unwarranted "gatekeeping."[10]

In 2012, Olson-Kennedy became the medical director of the Center for Transyouth Health and Development at Children’s Hospital Los Angeles, the largest transgender youth clinic in the United States as of 2024.[13] In 2015, she began to lead a $10 million NIH-funded research project to study youth gender medicine (described as "by far the largest such project in America").[by whom?][14][10]

In October 2024, the New York Times reported that Olson-Kennedy did not publish a study on puberty blockers from the NIH project which showed that they did not improve the mental health of children, due to concerns that the study's results could be used by political opponents in the US to argue in court that "we shouldn't use blockers because it doesn't impact [transgender adolescents]".[14] As summarized by the New York Times, other researchers[who?] involved in the study were "alarmed by the idea of delaying results that would have immediate implications for families around the world." However, other studies from the larger NIH project have been published, including one that found "improvements in life and body satisfaction" in transgender and nonbinary adolescents who took estrogen or testosterone as well as "declines in depression and anxiety."[14]

In December 2024, Olson-Kennedy was sued by a 20-year old female detransitioner, alleging she had caused permanent harm by a rushed diagnosis of gender dysphoria "mere minutes" after first seeing the plaintiff at age 12, who went on to receive puberty blockers and a double mastectomy at age 14.[15][13] The lawsuit also names the St. Francis Hospital in San Francisco and a second doctor as defendants, alleging that the latter had "rubber-stamped" the mastectomy.[13]

The same day, a group of Republican senators announced an inquiry into her unpublished NIH study. All senators involved except for one had previously sponsored a ban on youth gender-affirming care.[16]

See also

[edit]

Selected publications

[edit]
  • Olson-Kennedy, Johanna (2016-05-01). "Mental Health Disparities Among Transgender Youth: Rethinking the Role of Professionals". JAMA Pediatrics. 170 (5): 423–424. doi:10.1001/jamapediatrics.2016.0155. ISSN 2168-6203. PMID 26998945.
  • Olson-Kennedy, J; Cohen-Kettenis, P. T.; Kreukels, B.P.C; Meyer-Bahlburg, H.F.L; Garofalo, R; Meyer, W; Rosenthal, S.M. (April 2016). "Research Priorities for Gender Nonconforming/Transgender Youth: Gender Identity Development and Biopsychosocial Outcomes". Current Opinion in Endocrinology, Diabetes, and Obesity. 23 (2): 172–179. doi:10.1097/MED.0000000000000236. ISSN 1752-296X. PMC 4807860. PMID 26825472.
  • Olson, Johanna; Forbes, Catherine; Belzer, Marvin (2011-02-01). "Management of the Transgender Adolescent". Archives of Pediatrics & Adolescent Medicine. 165 (2): 171–176. doi:10.1001/archpediatrics.2010.275. ISSN 1072-4710. PMID 21300658.
  • Olson, Johanna; Garofalo, Robert (June 2014). "The peripubertal gender-dysphoric child: puberty suppression and treatment paradigms". Pediatric Annals. 43 (6): e132–137. doi:10.3928/00904481-20140522-08. ISSN 1938-2359. PMID 24972421.
  • Olson, Johanna; Schrager, Sheree M.; Belzer, Marvin; Simons, Lisa K.; Clark, Leslie F. (October 2015). "Baseline Physiologic and Psychosocial Characteristics of Transgender Youth Seeking Care for Gender Dysphoria". The Journal of Adolescent Health. 57 (4): 374–380. doi:10.1016/j.jadohealth.2015.04.027. ISSN 1879-1972. PMC 5033041. PMID 26208863.

References

[edit]
  1. ^ "Johanna Olson-Kennedy, MD". Children's Hospital Los Angeles. 2015-11-11. Retrieved 2020-02-01.
  2. ^ "Transgender Spectrum Conference" (PDF). Washington University in St. Louis. November 2016. Retrieved 2020-01-31.
  3. ^ a b Olson-Kennedy, J; Warus, J; Okonta, V; Belzer, M; Clark, LF (2018). "Chest Reconstruction and Chest Dysphoria in Transmasculine Minors and Young Adults: Comparisons of Nonsurgical and Postsurgical Cohorts". JAMA Pediatrics. 172 (5): 431–436. doi:10.1001/jamapediatrics.2017.5440. PMC 5875384. PMID 29507933.
  4. ^ a b Olson-Kennedy, Johanna; Cohen-Kettenis, Peggy T.; Kreukels, Baudewijntje P. C.; Meyer-Bahlburg, Heino F. L.; Garofalo, Robert; Meyer, Walter; Rosenthal, Stephen M. (April 2016). "Research priorities for gender nonconforming/transgender youth: gender identity development and biopsychosocial outcomes". Current Opinion in Endocrinology, Diabetes and Obesity. 23 (2): 172–179. doi:10.1097/MED.0000000000000236. ISSN 1752-2978. PMC 4807860. PMID 26825472.
  5. ^ a b Olson-Kennedy, Johanna; Okonta, Vivian; Clark, Leslie F.; Belzer, Marvin (April 2018). "Physiologic Response to Gender-Affirming Hormones Among Transgender Youth". The Journal of Adolescent Health. 62 (4): 397–401. doi:10.1016/j.jadohealth.2017.08.005. ISSN 1879-1972. PMC 7050572. PMID 29056436.
  6. ^ Schlanger, Zoë (2015-07-21). "Transgender Youth Don't Have Anything Wrong With Their Hormones". Newsweek.
  7. ^ "NY will soon make it easier for trans youths to delay puberty". PBS NewsHour. 2016-11-27. Retrieved 2020-02-01.
  8. ^ Peled, Shachar (29 December 2016). "Transgender boy is barred from Boy Scouts". CNN. Retrieved 2020-02-01.
  9. ^ Layden, Tim (28 June 2016). "American Hero: Jenner comfortable in her own skin". Sports Illustrated. Retrieved 2020-02-01.
  10. ^ a b c d "America's best-known practitioner of youth gender medicine is being sued". The Economist. ISSN 0013-0613. Retrieved 2024-12-07.
  11. ^ "The Impact of Early Medical Treatment in Transgender Youth". NIH. Retrieved October 23, 2024.
  12. ^ "America's best-known practitioner of youth gender medicine is being sued". The Economist. ISSN 0013-0613. Retrieved 2024-12-08.
  13. ^ a b c Barba, Sara; Libby, Michael (2024-12-06). "Woman sues California doctors, says she was rushed at age 12 into gender transition she regrets". San Francisco Chronicle. Retrieved 2024-12-07.
  14. ^ a b c Ghorayshi, Azeen (October 23, 2024). "U.S. Study on Puberty Blockers Goes Unpublished Because of Politics, Doctor Says". New York Times. Retrieved 2024-12-07.
  15. ^ Deese, Kaelan (6 December 2024). "Transgender youth doctor faces historic lawsuit: 'Damage has been done'". The Gazette. Retrieved 6 December 2024.
  16. ^ "Republican senators launch inquiry into unpublished NIH study on puberty blockers for trans youth". The Hill. 2024-12-06. Retrieved 2024-12-07.
[edit]
Stub icon

This biographical article related to medicine is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Johanna_Olson-Kennedy&oldid=1262820014"